Strides Pharma Science Limited has informed the Exchange regarding a press release dated December 18, 2020, titled "Strides receives USFDA approval for Oxybutynin Chloride Tablets".
Press Release Dec 18 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Nov 23 2020
- Press Release Oct 20 2020
- Press Release Sep 22 2020
- Press Release Sep 14 2020
- Press Release Sep 03 2020
Later from Strides Pharma Science
- Press Release Jan 08 2021
- Press Release Jan 15 2021
- Press Release Jan 25 2021
- Press Release Feb 04 2021
- Press Release Feb 12 2021
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science